1 Min Read
Feb 12 (Reuters) - Novavax Inc
* Initiates phase 1 clinical trial of Ebola vaccine in healthy subjects
* Novavax says “Ebola GP Vaccine can be rapidly scaled up to produce millions of doses” Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.